Find Federal Grants
National Institutes of Health · PAR-25-049
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-234
National Institutes of Health · PAR-25-136
National Institute of Corrections · 25JD11
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
National Institutes of Health · PAR-25-219
Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
National Institutes of Health · PAR-25-218
National Institutes of Health · PA-25-172
Bureau of African Affairs · DFOP0017004
DISRUPTIVE DC CONVERTERS FOR GRID RESILIENT INFRASTRUCTURE TO DELIVER SUSTAINABLE ENERGY SBIR/STTR (DC-GRIDS SBIR/STTR)
Advanced Research Projects Agency Energy · DE-FOA-0003500
DISRUPTIVE DC CONVERTERS FOR GRID RESILIENT INFRASTRUCTURE TO DELIVER SUSTAINABLE ENERGY (DC-GRIDS)
Advanced Research Projects Agency Energy · DE-FOA-0003499
U.S. Mission to Brazil · FY25-BSB-410601
Tanzania USAID-Dar es Salaam · 72062125RFA00001
Ethiopia USAID-Addis Ababa · 72060325RFI00001
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
National Institutes of Health · PAR-25-221
Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-063
National Institutes of Health · PAR-24-325
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
National Institutes of Health · PAR-25-079
Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed)
National Institutes of Health · PAR-25-198
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)
National Institutes of Health · PAR-25-199
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
National Institutes of Health · PAR-25-145